Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$34.56 - $57.55 $851,592 - $1.42 Million
-24,641 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $85,235 - $104,234
2,222 Added 9.91%
24,641 $983,000
Q2 2020

Aug 14, 2020

BUY
$31.78 - $51.19 $3,178 - $5,119
100 Added 0.45%
22,419 $1.01 Million
Q1 2020

May 15, 2020

SELL
$24.49 - $43.84 $530,649 - $949,925
-21,668 Reduced 49.26%
22,319 $750,000
Q4 2019

Jan 29, 2020

SELL
$24.06 - $32.51 $20,186 - $27,275
-839 Reduced 1.87%
43,987 $1.43 Million
Q3 2019

Oct 30, 2019

BUY
$23.81 - $32.52 $1.07 Million - $1.46 Million
44,826 New
44,826 $1.12 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.46B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.